Research progress on recurrence and metastasis factors for node negative breast cancer and its impact on treatment decisions
10.11904/j.issn.1002-3070.2015.02.019
- VernacularTitle:腋结阴性乳腺癌复发转移相关因素及其对治疗决策影响的研究进展
- Author:
Lina ZHEN
;
Changyan YU
;
Hongbin LI
;
Yue ZHANG
;
Qingyuan ZHANG
- Publication Type:Journal Article
- Keywords:
Node negative breast cancer;
Urokinase type plasminogen activator;
Oncotype DX;
Mamma-Print;
Tumor associated macrophages
- From:
Practical Oncology Journal
2015;(2):183-187
- CountryChina
- Language:Chinese
-
Abstract:
Node negative breast cancer is a prevalent form of breast cancer .With the improvement of breast cancer screening and disease awareness ,the rates of node negative breast cancer are gradually increasing . Although node negative breast cancer patients have much lower recurrence rates as compared with node positive patients,node-negative breast cancer is unequal to a low risk disease .Thus,it is important for oncologist to esti-mate the risk factors of node negative disease ,to carry out risk assessment and to guide the best regimen for these patients.In current review ,we discuss the value of traditional prognostic factors and new prognostic factors ,such as the urokinase -type plasminogen activator/plasminogen activator inhibitor 1,oncotype DX,MammaPrint and tumor associated macrophages ,on the predictive and treatment decisions in node negative breast cancer .
